Fermentalg SA has raised US$7 million
Fermentalg SA has raised US$7 million to bolster its R&D efforts in order to accelerate the industrialization process of its products.
Founded in 2009, Fermentalg is a biotechnology start-up specializing in the research and production of micro-algae. Its products are designed for applications in healthcare and cosmetics, as well as the agro-food and bio-fuel industries. The company is based in Libourne, France.
Oaklins’ team in France advised Fermentalg SA on this transaction.
Talk to the deal team
Related deals
Sun European Partners has secured financing to support its acquisition of B&H Worldwide
Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.
Learn moreInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreDolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn more